US general population food allergy treatment preferences: a discrete choice experiment

To quantify treatment preferences for food allergy management options (oral immunotherapy, biologic therapy, and allergen avoidance), overall and by sociodemographic strata. A US general population (≥13 years) discrete choice experiment (DCE) was conducted, including the Intolerance of Uncertainty-12 Scale and clinical/demographic questions. Conditional logistic regression analyses were conducted overall and by sociodemographic factors. DCE results were presented as odds ratios (ORs) with 95% confidence intervals (CIs). Participants (<i>n</i> = 294) mean (standard deviation) age was 47 (19.7) years; 48.6% were male. A 1% reduction in risk of having an exposure resulting in a moderate-to-severe reaction was statistically significantly associated with treatment preference (OR: 1.10; CI:1.04–1.16; <i>p</i> &lt; 0.01). Features significantly associated with reduced preference included: a 1% increase in risk of treatment-related, severe anaphylaxis (0.85; 0.74–0.97; <i>p</i>=0.02); a 1% increase in risk of gastrointestinal symptoms (0.99; 0.99–0.99; <i>p</i> &lt; 0.01); daily treatment (<i>vs.</i> every 2–4 weeks; 0.81; 0.72–0.91; <i>p</i> &lt; 0.01); in-clinic administration (<i>vs.</i> at-home; 0.76; 0.66–0.87; <i>p</i> &lt; 0.01); subcutaneous administration (<i>vs.</i> oral; 0.69; 0.61–0.78; <i>p</i> &lt; 0.01); three-hour post-treatment physical activity limitation (0.84; 0.77–0.93; <i>p</i> &lt; 0.01); and one-year life expectancy reduction (0.87; 0.85–0.89; <i>p</i> &lt; 0.01). Rural dwellers favoured at-home use and no activity limits; lower-income respondents preferred convenience (oral, less frequent, and at-home administration). Teens strongly preferred being bite-safe (<i>vs.</i> fully allergic; 2.75; 1.09–6.90; <i>p</i> = 0.03). When making food allergy management decisions, US general population respondents had strong preferences for features related to safety and convenience; however, the magnitude of preferences varied by sociodemographic factors. These findings may be pertinent for population-level health decision makers.

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28309115
Primary Topic
Food Allergy and Anaphylaxis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

US general population food allergy treatment preferences: a discrete choice experiment

Figshare
Food Allergy and Anaphylaxis Research
article

US general population food allergy treatment preferences: a discrete choice experiment

article en

Abstract

To quantify treatment preferences for food allergy management options (oral immunotherapy, biologic therapy, and allergen avoidance), overall and by sociodemographic strata. A US general population (≥13 years) discrete choice experiment (DCE) was conducted, including the Intolerance of Uncertainty-12 Scale and clinical/demographic questions. Conditional logistic regression analyses were conducted overall and by sociodemographic factors. DCE results were presented as odds ratios (ORs) with 95% confidence intervals (CIs). Participants (<i>n</i> = 294) mean (standard deviation) age was 47 (19.7) years; 48.6% were male. A 1% reduction in risk of having an exposure resulting in a moderate-to-severe reaction was statistically significantly associated with treatment preference (OR: 1.10; CI:1.04–1.16; <i>p</i> &lt; 0.01). Features significantly associated with reduced preference included: a 1% increase in risk of treatment-related, severe anaphylaxis (0.85; 0.74–0.97; <i>p</i>=0.02); a 1% increase in risk of gastrointestinal symptoms (0.99; 0.99–0.99; <i>p</i> &lt; 0.01); daily treatment (<i>vs.</i> every 2–4 weeks; 0.81; 0.72–0.91; <i>p</i> &lt; 0.01); in-clinic administration (<i>vs.</i> at-home; 0.76; 0.66–0.87; <i>p</i> &lt; 0.01); subcutaneous administration (<i>vs.</i> oral; 0.69; 0.61–0.78; <i>p</i> &lt; 0.01); three-hour post-treatment physical activity limitation (0.84; 0.77–0.93; <i>p</i> &lt; 0.01); and one-year life expectancy reduction (0.87; 0.85–0.89; <i>p</i> &lt; 0.01). Rural dwellers favoured at-home use and no activity limits; lower-income respondents preferred convenience (oral, less frequent, and at-home administration). Teens strongly preferred being bite-safe (<i>vs.</i> fully allergic; 2.75; 1.09–6.90; <i>p</i> = 0.03). When making food allergy management decisions, US general population respondents had strong preferences for features related to safety and convenience; however, the magnitude of preferences varied by sociodemographic factors. These findings may be pertinent for population-level health decision makers.

Figshare
Zero hunger
Openalex Percentile: Top 46%
Food Allergy and Anaphylaxis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

US general population food allergy treatment preferences: a discrete choice experiment · Figshare (2025) | TGRS Research Map | TGRS